GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (HKSE:01167) » Definitions » Preferred Dividends

Jacobio Pharmaceuticals Group Co (HKSE:01167) Preferred Dividends : HK$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Jacobio Pharmaceuticals Group Co's preferred dividends for the six months ended in Dec. 2023 was HK$0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.00 Mil.


Jacobio Pharmaceuticals Group Co Preferred Dividends Historical Data

The historical data trend for Jacobio Pharmaceuticals Group Co's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobio Pharmaceuticals Group Co Preferred Dividends Chart

Jacobio Pharmaceuticals Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Preferred Dividends
Get a 7-Day Free Trial - - - - -

Jacobio Pharmaceuticals Group Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Preferred Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Jacobio Pharmaceuticals Group Co Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.


Jacobio Pharmaceuticals Group Co  (HKSE:01167) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jacobio Pharmaceuticals Group Co (HKSE:01167) Business Description

Traded in Other Exchanges
Address
No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN
Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.
Executives
Shen Zhu 2501 Other
Treasure Partner International Limited 2501 Other
Ultimate Estate Limited 2201 Interest of corporation controlled by you
Wang Yinxiang 2501 Other
Wang Xiaojie 2307 Founder of a discretionary trust who can infl
Hu Yunyan 2501 Other
Yakovpharma Ltd 2501 Other
Willgenpharma Ltd 2501 Other
Risepharma Ltd 2101 Beneficial owner
Johwpharma Ltd 2501 Other
Hmed Ltd 2501 Other
Gloryviewpharma Ltd 2501 Other
Honourpharma Ltd 2501 Other
Blesspharma Ltd 2501 Other
Hillhouse Investment Management, Ltd. 2102 Investment manager

Jacobio Pharmaceuticals Group Co (HKSE:01167) Headlines

No Headlines